| Application no. and date | 04798998.3 (espacenet) (Federated) (European Patent Register), 20041105 | | Patent/reg. no. and date | DK/EP 1692182, 20100407 | | Publication date | 20060823 | | Priority no. and date | US 517096 P, 20031105 | | EP pub. no. and date |
EP 1692182 20060823 | | Effective date | | | Applicant/owner | Roche Glycart AG, Wagistrasse 18
8952 Schlieren-Zuerich, CH | | Applicant ref. no. | P47034DK01 | | Inventor | UMANA, Pablo, Freistrasse 159
CH-8032 Zurich, CH,
BRÜNKER, Peter, Burgwiesenstrasse 3c
CH-8335 Hittnau, CH,
MÖSSNER, Ekkehard, Zeppelinstrasse 13
CH-8280 Kreuzlingen, CH,
SUTER, Tobias, Dorfstrasse 16
CH - 5210 Windisch, CH,
PÜNTENER, Ursula, Dorfstrasse 16
CH - 5210 Windisch, CH,
FERRARA KOLLER, Claudia, Göblistrasse 12
CH - 6300 Zug, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 16/28 (2006.01) | | Title | CD20-antistoffer med øget Fc-receptorbindingsaffinitet og effektorfunktion | | Int. application no. | IB2004003896 | | Int. publication no. | WO2005044859 | | Related patent (certificate) | CA 2015 00001 | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
